MEDINET Co., Ltd. Reports Earnings Results for the Second Quarter Ended March 2021
May 12, 2021 at 02:00 am EDT
Share
MEDINET Co., Ltd. reported earnings results for the second quarter ended March 2021. For the second quarter, the company reported net sales of JPY 274 million compared to JPY 506 million a year ago. Operating loss was JPY 545 million compared to JPY 372 million a year ago. Loss was JPY 509 million or JPY 3.02 per basic share compared to JPY 362 million or JPY 2.89 per basic share a year ago.
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
MEDINET CO., LTD. 
